← Leaderboards
Quanyin Hu
University Of Wisconsin-Madison
$1,705,206
Attributed
$1,705,206
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2024–25$2M$1.5M$1M$500K$0
'24
'25
Funding mix
By agency
NIH$1,705,206 · 2
By mechanism
R01$1,705,206 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Wisconsin-Madison
Same institution · by research overlap
- Ethan Lippmann$8,201,254
- Shaoqin - Gong$18,047,338
- Weiping Tang$8,211,161
- Zachary Campbell$4,686,519
- Todd D Krauss$425,160
Others in their field
Other Rising Stars on “Mouse Model”
- Suma Babu · Massachusetts General Hospital$25,017,559
- Sabrina Paganoni · Massachusetts General Hospital$25,017,559
- Warwick Britton · University Of Sydney$10,964,476
- Lisa Wagar · University Of California-Irvine$5,972,985
- John Paderi John Paderi John Paderi · Ihp Therapeutics, Inc.$5,881,537
- Fergal James Martin · University Of California Santa Cruz$5,089,409
Research focus
Mouse ModelPrognosisImmunotherapeutic AgentMelanomaPatient Derived Xenograft ModelCombined Modality TherapyClinicImmune Checkpoint InhibitorCirculationIntravenous InjectionOperative Surgical ProceduresPathway InteractionsBreast Cancer ModelBreast Cancer PatientAntibodiesCancer ImmunotherapyEncapsulatedImmuneCancer SiteChemotherapyBlood PlateletsImmunotherapyCellsRelapse
Grant awards (3)
Improving the platelet-mediated immune checkpoint inhibitor delivery for treating triple-negative breast cancer$619,764
R01 · FY2025 · CA · contact PI
Engineering ferritin degrader-encapsulated platelets for post-surgical TNBC treatment$542,721
R01 · FY2025 · EB · contact PI
Engineering ferritin degrader-encapsulated platelets for post-surgical TNBC treatment$542,721
R01 · FY2024 · EB · contact PI